Simplify Logo

Full-Time

Director Clinical Operations Rare Disease

Confirmed live in the last 24 hours

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Consulting
Biotechnology

Senior, Expert

Princeton, NJ, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Management
Requirements
  • Bachelor’s degree in the life sciences or related field; Advanced degree preferred.
  • Targeting 10 years’ clinical development and management experience, with significant clinical trials experience and 8 years’ proven experience in a leadership and people management role.
  • Experience leading and managing complex global clinical development programs is required.
  • Superior verbal, written, and presentation communication skills in relating to colleagues and associates both inside and outside the organization.
  • Demonstrated track record of translating senior level research/scientific business requirements into operational strategies globally.
  • Has broad experience selecting, managing, troubleshooting and negotiating with CROs and other vendors.
  • Thorough understanding of local and international regulations applicable to clinical development; demonstrative knowledge of regulatory requirements globally and prior success in providing timely and quality support of regulatory submissions.
  • Practical experience in clinical trial strategies, methods and processes; deep knowledge of clinical trial design.
  • Demonstrated technical, administrative, and project management capabilities.
  • Adept at creating and communicating a clear vision among direct reports, effectively aligning resources and motivating teams to achieve goals.
  • Demonstrated analytical abilities and proficient planning and negotiation skills.
  • Strong interpersonal, organizational and workload planning skills along with excellent verbal and written communication skills.
  • Demonstrated success with cross-functional collaboration and managing multiple assignments with timely and accurate output.
  • Ability to travel 25% of the time.
Responsibilities
  • Provide leadership and expertise in the global operational strategy and directing project teams to support clinical study planning and execution within the CNS AND/OR RARE DISEASE THERAPEUTICA AREA, STRONGLY DESIREDResponsible for the development and management of all operational timelines and budget for programs under the respective therapeutic area.
  • Responsible for providing operational input for development plans in support of the asset strategy.
  • Represent the respective therapeutic area for senior management as needed.
  • Leads the strategy and tactics to successfully work with vendors, investigators, other departments within ACADIA, and the program clinicians to develop, execute and deliver clinical programs supporting drug development while ensuring quality, speed, budget, and regulatory compliance.
  • Evaluates, refines, and makes recommendations for various operational constructs for study execution.
  • Leads and shares best practices with internal and external stakeholders, as appropriate.
  • Establishes performance, quality, business efficiency and innovation metrics for clinical teams; addresses systematic deficiencies and seeks to improve quality across study programs.
  • Maintains awareness of industry trends and developments to help define the future strategic direction for the clinical programs.
  • Provides direction in the development and oversight of study plans to ensure quality processes are followed.
  • Responsible for direct management of Clinical Operations team members in the respective therapeutic area to ensure consistent application of best practice and execution.
  • Supports mentoring and training of Clinical Operations staff in the respective therapeutic area.
  • Participates in and/or leads process improvements within/between cross functional areas to increase efficiencies and manage costs.
  • Develops and measures appropriate metrics to assess and improve vendor and site performance.
  • Ensures that cross-functional process efficiencies are identified and maximized in accordance with project goals.
  • Oversees and is accountable for appropriate resource planning to support specific therapeutic area.
  • Participates in the selection, management and oversight of CROs and other vendors, driving quality performance to milestones and deliverables.
  • Other responsibilities as required.
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.